Company Merck KGaA

MRK

DE0006599905

Pharmaceuticals

Market Closed - Xetra Other stock markets 16:42:01 18/06/2025 BST			5-day change	1st Jan Change
109.70 ^EUR	-2.14%		-5.43%	-21.59%

06-12	Merck: EMD Serono Presents Results On Efficacy And Safety Of Enpatoran	RE
06-10	China's Center for Drug Evaluation Accepts Merck KGaA's Application for Marketing Authorization of Pimicotinib for Treatment of Tenosynovial Giant Cell Tumor	CI

Business description: Merck KGaA

Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows:

- solutions and products for scientific and biotechnological research (42.1%);

- pharmaceutical products (40%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.;

- performance materials for the electronics industry (17.9%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc.

Net sales are distributed geographically as follows: Germany (4.7%), Switzerland (1.9%), Europe (22.6%), the United States (25.7%), North America (1.3%), China (13.5%), Asia/Pacific (19.6%), Latin America (7%), Middle East and Africa (3.7%).

Number of employees: 62,604

Sales by Activity: Merck KGaA

Fiscal Period: December	2020	2021	2022	2023	2024
Life Science	7.53B	9.05B	10.44B	9.36B	9.01B
Healthcare	6.64B	7.09B	7.84B	8.05B	8.46B
Electronics	3.38B	3.61B	4.01B	3.66B	3.78B
Corporate and Other	-18M	-62M	-61M	-77M	-91M

See all business segments

Geographical breakdown of sales: Merck KGaA

Fiscal Period: December	2020	2021	2022	2023	2024
USA	4.64B	5.25B	6.3B	5.91B	5.65B
Other Europe	3.55B	4.03B	4.52B	4.4B	4.5B
Asia-Pacific (Excluding China)	3.74B	4.09B	4.48B	4.18B	4.14B
China	2.22B	2.55B	2.82B	2.48B	2.58B
Latin America	868M	947M	1.18B	1.27B	1.43B
Germany	1.5B	1.66B	1.53B	1.42B	1.41B
Switzerland	462M	529M	592M	512M	594M
Middle East and Africa (MEA)	361M	404M	516M	535M	590M
North America (Excluding USA)	191M	225M	294M	287M	263M

See all geographic segments

Executive Committee: Merck KGaA

Manager	Title	Age	Since
Belén Garijo López CEO	Chief Executive Officer	63	30/04/2021
Helene von Roeder DFI	Director of Finance/CFO	55	30/06/2023
Laura Matz CTO	Chief Tech/Sci/R&D Officer	-	30/06/2021
Constantin Fest IRC	Investor Relations Contact	-	-
Karen N. Madden PRN	Corporate Officer/Principal	-	-

See MERCK KGAA governance

Composition of the Board of Directors: Merck KGaA

Director	Title	Age	Since
Christian Raabe BRD	Director/Board Member	-	25/04/2019
Jürgen Glaser BRD	Director/Board Member	62	30/04/2012
Helga Rübsamen-Schaeff BRD	Director/Board Member	76	08/05/2014
Gabriele Eismann BRD	Director/Board Member	63	08/05/2014
Dietmar Oeter BRD	Director/Board Member	58	08/05/2014
Alexander Putz BRD	Director/Board Member	48	08/05/2014
Sascha Held BRD	Director/Board Member	-	25/04/2019
Michael Kleinemeier CHM	Chairman	68	31/01/2024
Renate Koehler BRD	Director/Board Member	-	25/04/2019
Anne Lange BRD	Director/Board Member	-	25/04/2019

Composition of the Board of Directors

Shareholders: Merck KGaA

Name	Equities	%	Valuation
First Eagle Investment Management LLC 4.986 %	6,444,351	4.986 %	845 M €
Amundi Asset Management SASU (Investment Management) 0.4881 %	630,861	0.4881 %	83 M €
Capfi Delen Asset Management NV 0.2857 %	369,206	0.2857 %	48 M €
State Street Global Advisors Ltd. 0.2258 %	291,863	0.2258 %	38 M €
Lazard Asset Management Ltd. 0.2144 %	277,054	0.2144 %	36 M €

Name	Equities	%	Valuation
First Eagle Investment Management LLC 0.0797 %	514,942	0.0797 %	14 M €
Henry James International Management, Inc. 0.0109 %	70,205	0.0109 %	2 M €
Domini Impact Investments LLC 0.003203 %	20,700	0.003203 %	542 837 €
RhumbLine Advisers LP 0.002073 %	13,396	0.002073 %	351 297 €
Yousif Capital Management LLC 0.001551 %	10,021	0.001551 %	262 791 €

List of MERCK KGAA shareholders

Holdings: Merck KGaA

Name	Equities	%	Valuation
MOONLAKE IMMUNOTHERAPEUTICS 4.4%	2,787,509	4.4%	108,740,726 $
PT MERCK TBK 86.65%	388,194,920	86.65%	86,264,675 $
VERA THERAPEUTICS, INC. 3.02%	1,913,501	3.02%	36,260,844 $
PRECIGEN, INC. 7.05%	20,647,152	7.05%	27,254,241 $

Company details: Merck KGaA

Merck KGaA

Frankfurter Strasse 250

64293, Darmstadt

+49 6151 72 0

http://www.merckgroup.com

Group companies: Merck KGaA

Name	Category and Sector
Merck Finance II SARL
Sigma-Aldrich Pte Ltd. Sigma-Aldrich Pte Ltd. Chemicals: SpecialtyProcess Industries Part of Merck KGaA, Sigma-Aldrich Pte Ltd. is a Singaporean company that manufactures and supplies biochemical and organic chemical products. The company is located in Singapore.	Chemicals: Specialty
Merck SA Merck SA Pharmaceuticals: OtherHealth Technology Part of Merck KGaA, Merck SA is a Colombian company that manufactures pharmaceutical and chemical products. The company is based in Bogota, Colombia. The CEO of the company is Silvia Catalina Ricaurte Farfan.	Pharmaceuticals: Other
Merck Capital Ltd.
Merck Invest SCS

See all subsidiaries

Specialty & Advanced Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
MERCK KGAA	-2.14%	-5.43%	-35.15%	-30.64%	56.17B
KYOWA KIRIN CO., LTD.	-0.46%	-0.26%	-7.33%	-15.08%	8.95B
HALOZYME THERAPEUTICS, INC.	+0.02%	-1.36%	+5.67%	+20.34%	6.54B
YUHAN CORPORATION	-0.96%	-3.26%	+37.17%	+110.16%	5.68B
SK BIOPHARMACEUTICALS CO., LTD.	-0.11%	-2.36%	+18.34%	+30.75%	5.2B
BETTA PHARMACEUTICALS CO., LTD.	-2.94%	-10.91%	+52.80%	+0.53%	3.4B
SUPERNUS PHARMACEUTICALS, INC.	+1.96%	-0.57%	+23.63%	+21.98%	2.02B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	-1.76%	-3.73%	-2.49%	+17.17%	2.01B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+0.33%	-3.58%	-59.43%	-9.96%	1.76B
INDIVIOR PLC	+0.97%	+2.67%	-18.06%	-27.14%	1.73B
Average	-0.49%	-3.00%	+1.51%	+11.81%	9.35B
Weighted average by Cap.	-1.46%	-4.25%	-17.22%	-9.85%